two
wellknown
antibiot
heterocycl
quinolon
nalidix
acid
blactam
penicillin
v
activ
differ
level
bacteri
growth
process
attach
via
etherest
junction
ptertbutylcalix
aren
lower
rim
altern
posit
result
hydrophob
molecular
drugorganis
fulli
character
evalu
two
gram
neg
three
gram
posit
refer
strain
use
disk
diffus
assay
disk
impregn
solut
titl
compound
pure
dmso
interest
activ
observ
staphylococcu
aureu
atcc
dissymmetr
podand
incorpor
one
penicillin
one
nalidix
ester
moieti
due
intrins
physicochem
chemic
properti
calixaren
often
employ
last
year
carrier
spatial
organis
variou
kind
activ
substitu
display
properti
deal
recognit
organ
substrat
metal
cation
organis
properti
could
great
interest
build
molecular
drugorganis
dispens
notabl
medic
valuabl
structur
incorpor
probe
drug
last
case
biochem
control
releas
expect
result
edific
drugcarri
prodrug
behaviour
result
oligomer
structur
could
thu
consid
sizeintermedi
discret
drug
polymer
one
latter
emerg
last
year
apparit
said
polym
therapeut
use
polymer
drug
hybrid
polym
drug
polymer
micel
contain
coval
link
drug
recent
review
de
fatima
et
al
kalchenko
cowork
report
essenti
form
patent
describ
therapeut
activ
calixaren
deriv
hydrophil
shown
interest
activ
bacteria
fungi
cancer
cell
envelop
virus
also
thrombosi
fibros
diseas
biolog
studi
relat
plasmid
dna
bind
cell
transfect
recent
report
ungaro
cowork
middl
calixaren
deriv
macrocyclon
recent
parent
structur
studi
treatment
tuberculosi
mycobacterios
calixarenebas
mimic
vancomycin
also
describ
field
contribut
devot
design
new
antihiv
anticorona
viru
agent
regard
spread
resist
pathogen
microorgan
actual
antibiot
antibacteri
agent
parallel
approach
synthesi
new
compound
thought
molecular
drugorganis
dispens
base
calixaren
platform
display
lower
rim
penicillin
said
quinolon
moieti
attach
via
labil
bound
first
molecular
target
antibiot
penicillin
graft
altern
posit
cone
conform
oacetyl
ptertbutylcalix
aren
via
amid
link
involv
extern
amino
group
structur
consid
pure
blactam
antibiot
calixaren
subunit
play
role
extern
amid
function
investig
synthet
approach
involv
labil
ester
junction
appli
nalidix
acid
first
deriv
said
quinolon
famili
penicillin
antibiot
deriv
suppos
synergist
antibacteri
effect
could
occur
incorpor
see
front
matter
elsevi
ltd
right
reserv
differ
kind
known
antibiot
speci
spatial
organis
calixaren
deriv
incorpor
variou
penicillin
quinolon
subunit
also
prepar
sens
present
synthesi
character
antibacteri
evalu
dmso
solut
disk
diffus
assay
dissymetr
podand
bear
one
penicillin
one
quinolon
penicillin
v
nalidix
acid
bound
distal
lower
rim
ptertbutylcalix
aren
labil
propyl
linker
correspond
bisnalidix
bispenicillin
v
bishydroxypropyl
deriv
scheme
respect
penicillin
v
potassium
salt
pvk
nalidix
acid
na
previou
result
show
first
penicillin
ester
oalkoxi
calixaren
obtain
via
reaction
penicillin
salt
bromoalkyl
calixaren
forc
introduct
bromoalkyl
arm
preliminar
step
secondli
adapt
pathway
salt
nalidix
acid
parent
compound
uneasi
tediou
contrario
oalkyl
calixaren
bromoalkyl
deriv
sens
format
bromopropyl
calixaren
discard
addit
choic
done
introduc
penicillin
moieti
last
step
order
avoid
degrad
phsensit
unit
thu
decid
prepar
first
monobromopropylcalixaren
alkyl
opposit
posit
bromopropyl
nalidix
obtain
introduc
penicillin
moieti
bromopropyl
arm
scheme
synthesi
perform
condit
favour
monosubstitut
reaction
equiv
ptertbutylcalix
aren
presenc
equiv
k
co
dri
mecn
thu
obtain
yield
purif
chromatographi
reaction
bromopropylnalidix
presenc
equiv
k
co
dri
mecn
afford
podand
incorpor
penicillin
v
onto
residu
bromin
arm
perform
dri
dmf
inert
atmospher
react
excess
potassium
salt
penicillin
v
pvk
podand
form
thu
isol
pure
chromatographi
yield
ester
prepar
describ
chosen
start
materi
synthesi
alcohol
scheme
choic
done
observ
degrad
methylnalidix
silica
gel
chromatographi
deriv
methanol
use
constitu
mobil
phase
appli
solut
directli
onto
give
yield
chromatographi
prepar
yield
direct
reaction
pvk
calixaren
dri
dmf
ar
compound
fulli
character
notabl
nmr
element
analysi
esmass
spectrometri
gave
result
consist
propos
formula
structur
complex
speci
necessit
high
resolut
nmr
experi
cosi
hmqc
hmbc
assign
far
possibl
reson
signal
h
c
nmr
show
cone
conform
maintain
arch
ar
reson
signal
appear
ab
system
ca
equatori
h
ca
axial
h
ppm
ca
ppm
ch
respect
integr
blactam
structur
fragil
penicillin
subunit
verifi
compound
well
h
nmr
presenc
expect
reson
signal
ppm
j
hz
h
ppm
dd
j
hz
j
hz
h
ir
spectroscopi
presenc
penam
carbonyl
group
band
ca
cm
preliminar
biolog
investig
attempt
solid
liquid
phase
variou
gram
posit
gram
neg
bacteria
nevertheless
lack
solubl
aqueou
media
amphiphil
compound
use
studi
airwat
interfac
fact
deleteri
bacteriolog
studi
solut
amount
dmso
necessari
cosolubilis
podand
water
much
higher
admit
liquid
phase
antibacteri
assay
verifi
sens
dmso
depend
concentr
water
could
act
alon
antibacteri
agent
solid
phase
antibiot
disk
diffus
assay
perform
muellerhinton
agar
steril
mm
diamet
disk
impregn
differ
quantiti
compound
volatil
organ
solvent
dri
prior
deposit
growth
inhibit
surfac
around
cellulos
disk
observ
interpret
either
lack
activ
lack
solubl
diffus
titl
compound
reason
solid
phase
approach
attempt
use
disk
impregn
pure
dmso
solut
compound
take
account
probabl
antibacteri
activ
solvent
fact
even
solvent
introduc
veterinarian
medicin
clinic
medicin
experiment
agent
middl
centuri
found
clear
inform
concern
use
pure
dmso
antibacteri
agent
singl
solvent
drug
test
liquid
solid
phase
antibacteri
assay
present
work
dmso
use
pure
vehicl
solubilis
compound
impregn
steril
cellulos
disk
impli
use
disk
impregn
dmso
alon
order
check
activ
refer
bacteri
strain
use
assay
antibacteri
assay
conduct
accord
clsi
recommend
three
gram
posit
refer
strain
staphylococcu
aureu
atcc
aureu
atcc
enterococcu
faecali
atcc
well
two
gram
neg
refer
strain
e
coli
atcc
pseudomona
aeruginosa
atcc
dmso
solut
nalidix
acid
na
potassium
salt
penicillin
v
pvk
preliminari
evalu
pure
binari
mixtur
concentr
equival
maximum
dose
releas
calixaren
deriv
present
studi
shown
figur
dmso
exhibit
activ
pseudomona
aeruginosa
atcc
imag
v
growth
inhibit
diamet
equival
four
disk
one
suppos
dmso
na
andor
pvk
display
activ
bacteri
strain
e
coli
atcc
na
exhibit
moder
activ
pvk
littl
one
e
faecali
sensit
antibacteri
agent
expect
aureu
atcc
strain
scheme
symmetr
calixaren
deriv
present
studi
display
sensit
antibacteri
agent
respect
inhibit
diamet
penicillin
much
lesser
atcc
strain
exhibit
strong
sensit
toward
pvk
calixaren
deriv
present
studi
dissolv
pure
dmso
concentr
correspond
maximum
releas
hydrolysi
occur
lg
penicillin
v
ca
lg
tabl
result
given
figur
confirm
first
dmso
central
disk
exhibit
antibacteri
behavior
except
p
aeruginosa
atcc
imag
v
dmso
solut
compound
display
similar
growth
inhibit
diamet
inhibit
zone
found
aureu
atcc
imag
ii
e
faecali
atcc
imag
iii
e
coli
atcc
imag
iv
substanc
dmso
solut
dialcohol
bi
nalidix
deriv
bispenicillin
exhibit
activ
refer
strain
import
growth
inhibit
found
dissymmetr
compound
contain
one
penicillin
one
nalidix
arm
aureu
atcc
disk
imag
inhibit
diamet
mm
littl
one
observ
strain
bispenicillin
strain
exhibit
natur
resist
nalidix
acid
penicillin
v
second
seri
experi
conduct
compound
old
fresh
solut
pvk
order
reach
similar
releas
quantiti
penicillin
v
tabl
figur
result
given
figur
confirm
previou
observ
quasi
lack
activ
e
faecali
atcc
e
coli
atcc
modest
activ
pvk
aureu
atcc
e
faecali
atcc
gener
dmsorel
activ
p
aeruginosa
atcc
imag
show
aureu
atcc
strain
exhibit
high
sensit
pvk
low
one
dmso
old
month
fresh
solut
compound
give
quit
similar
figur
expect
accept
linear
relat
concentr
inhibit
diamet
thu
penicillin
vcontain
calixaren
deriv
studi
compound
display
antibacteri
activ
aureu
atcc
pronounc
dissymmetr
deriv
result
obtain
compound
aureu
atcc
could
explain
specif
hydrolysi
penicillin
ester
linkag
surprisingli
occur
similar
level
bi
penicillin
ester
growth
inhibit
zone
appear
analogu
aureu
atcc
strain
pvk
moder
activ
lead
us
consid
enzymat
hydrolyt
process
specif
aureu
atcc
strain
addit
well
defin
aureu
atcc
weak
betalactamaseproduc
strain
also
explain
discrep
observ
two
strain
pvk
conclus
found
pure
dmso
exhibit
antibacteri
effect
three
gram
posit
refer
strain
aureu
atcc
aureu
atcc
e
faecali
atcc
well
gram
neg
refer
strain
e
coli
atcc
contrario
activ
observ
gram
neg
refer
strain
p
aeruginosa
atcc
use
pure
solvent
known
drug
investig
antibacteri
properti
new
substanc
nevertheless
care
must
taken
concern
possibl
synergist
effect
found
calixaren
deriv
integr
one
penicillin
v
one
nalidix
acid
subunit
tether
via
labil
ester
linkag
calixaren
core
express
interest
activ
aureu
atcc
strain
call
deeper
investig
frontier
biolog
physicochemistri
involv
drug
titrat
modelis
hydrolysi
airwat
interfac
membran
model
order
understand
exhibit
activ
evalu
role
calixaren
moieti
vs
possibl
synergist
effect
well
evalu
antibacteri
properti
lipophil
prodruglik
design
calixaren
deriv
melt
point
uncorrect
determin
electrotherm
capillari
apparatu
h
c
nmr
spectra
record
bruker
drx
chemic
shift
ppm
mass
spectra
electron
ionisationei
electrospray
record
nermag
apparatu
micromass
platform
ii
apparatu
respect
servic
commun
de
de
mass
organiqu
nanci
infrar
perform
bruker
vector
apparatu
kbr
cm
uv
spectra
record
safa
uv
mc
apparatu
k
max
nm
e
mol
dm
cm
element
analys
perform
servic
de
microanalys
nanci
merck
tlc
plate
use
chromatographi
analysi
sio
ref
al
ref
commerci
avail
product
use
without
purif
unless
otherwis
specifi
suspens
ptertbutylcalix
aren
g
mol
k
co
g
mol
dri
mecn
ml
reflux
min
ml
mol
ad
reflux
maintain
h
solvent
evapor
solid
residu
dissolv
ch
cl
result
solut
wash
h
dri
na
concentr
cool
result
precipit
filter
filtrat
chromatograph
sio
ch
cl
hexan
give
g
mixtur
monobromopropylcalix
aren
g
mol
k
co
g
mol
dri
mecn
ml
reflux
ar
min
bromopropyl
nalidix
g
mol
ad
reflux
continu
h
solvent
evapor
dryness
residu
dissolv
ch
mol
mixtur
dri
chcl
ml
etoh
ml
reflux
h
tlc
monitor
silica
gel
filter
rins
ml
mixtur
ch
cl
etoh
combin
filtrat
evapor
semisolid
residu
dissolv
ch
cl
evapor
solid
materi
obtain
latter
tritur
dri
et
ml
filter
filtrat
evapor
dryness
residu
g
chromatograph
sio
ch
cl
etoh
separ
ethyl
nalidix
desir
diol
semiglassi
materi
latter
tritur
mixtur
pentan
et
give
diol
g
antibacteri
activ
evalu
muellerhinton
agar
use
antibiot
disk
diffus
assay
steril
mm
diamet
disk
impregn
dmso
solut
nalidix
acid
na
potassium
salt
penicillin
v
pvk
prepar
concentr
equival
maximum
dose
releas
calixaren
deriv
dmso
solut
calixaren
prepar
concentr
correspond
maximum
releas
hydrolysi
occur
lg
penicillin
v
ca
lg
nalidix
acid
cellulos
disk
plate
incub
read
h
incub
